Look you can hand pick "risk factors" for any company. Fact is we have an exclusive partnership with the only institution in the us that is permitted federally to research medical marijuana and it's derivatives. We have eight drug candidates and multiple partnerships with different pharmaceutical development companies to prepare our candidates for human clinical trials. Even if one our our candidates becomes commercialized it' would be a massive revenue generater. The share structure is amazing, axim and cnbx have no revenues and look at their market cap. You have to be a fool to have a bearish opinion on nemus.
News 
Market Data 
Discover 
